BIOY vs JEPQ5YBIOYBIOYAvsBJEPQJEPQGraniteShares YieldBOOST Biotech ETF · $2MJPMorgan Nasdaq Equity Premium Income ETF · $40.8BReturns · dividends in[…]3 years · per year[…] · $15,623+16.0%[…]5 years · per year[…]Cost and income14.98%Expense ratio$1,498 · $35 on $10k · lower wins0.35%38.06%12-mo yield$3,806 · $1,271 on $10k12.71%Risk · 1 year
$10,000 in BIOY, JEPQ, VIG5Y$10k startVIG $16.1kNov 2021Nov 2026End-of-day Nov 18, 2026 · growth of $10,000, dividends reinvested · from each fund’s start inside the window
Overlap: BIOY, JEPQ, VIGToday26.3%most shared, JEPQ and VIGBIOYJEPQVIGBIOY—[…][…]JEPQ[…]—26.3%VIG[…]26.3%—End-of-day Nov 18, 2026 · share held in common · outlined: the pair in versus
BIOY vs JEPQ5YABIOYGraniteShares YieldBOOST Biotech[…]vsJEPQBJPMorgan Nasdaq Equity Premium Income[…]MeasureBIOYJEPQFee14.98%0.35%Cost on $10k a year$1,498$35Yield38.06%12.71%5 years, per year[…][…]3 years, per year[…]+16.0%Worst drop · 1Y[…]−11.5%Volatility · 1Y[…]17.1%
All Three5Y3 fundsBest 5YLowest feeHighest incomeSmallest dropMost assets#Ticker▲▼Fund▲▼TrendFee▲▼Yield▲▼Today▲▼YTD▲▼1Y▲▼3Y/yr▲▼5Y/yr▼10Y/yr▲▼Drop▲▼Assets▲▼1VIGVanguard Dividend Appreciation ETFReadDesk0.04%1.49%−0.8%+12.5%+15.5%+17.5%+10.0%+13.5%−7.9%$115.8B2ABIOYGraniteShares YieldBOOST Biotech ETFReadDesk14.98%38.06%+0.1%newnewnewnew—[…]$2M3BJEPQJPMorgan Nasdaq Equity Premium Income ETFReadDesk0.35%12.71%+0.4%+3.9%+7.1%+16.0%new—−11.5%$40.8BEnd-of-day Nov 18, 2026 · total return, dividends in · 3Y, 5Y and 10Y per year · A and B = the pair in versus
All Three5Y3 fundsBest 5YLowest feeHighest incomeSmallest dropMost assets#Ticker▲▼Fund▲▼TrendFee▲▼Yield▲▼Today▲▼YTD▲▼1Y▲▼3Y/yr▲▼5Y/yr▼10Y/yr▲▼Drop▲▼Assets▲▼1VIGVanguard Dividend Appreciation ETFReadDesk0.04%1.49%−0.8%+12.5%+15.5%+17.5%+10.0%+13.5%−7.9%$115.8B2ABIOYGraniteShares YieldBOOST Biotech ETFReadDesk14.98%38.06%+0.1%newnewnewnew—[…]$2M3BJEPQJPMorgan Nasdaq Equity Premium Income ETFReadDesk0.35%12.71%+0.4%+3.9%+7.1%+16.0%new—−11.5%$40.8BEnd-of-day Nov 18, 2026 · total return, dividends in · 3Y, 5Y and 10Y per year · A and B = the pair in versus
SCHD vs VIGYTDSchwabSCHDSA+29.6%vsBVVIGVanguard+12.5%Jan 1Nov 18+29.6%+12.5%+29.6%Year to date+12.5%3.0%Yield1.5%$122BAssets$116B2–0SCHD winsEnd-of-day Nov 18, 2026
JEPQ vs JEPIYTDJ.P. MorganJEPQJMA+3.9%vsBJMJEPIJ.P. Morgan+5.6%Jan 1Nov 18+3.9%+5.6%+3.9%Year to date+5.6%12.7%Yield8.1%$40.8BAssets$46.0B1–1levelEnd-of-day Nov 18, 2026
DGRO vs VIGYTDiSharesDGROiSA+16.2%vsBVVIGVanguard+12.5%Jan 1Nov 18+16.2%+12.5%+16.2%Year to date+12.5%1.9%Yield1.5%$44.7BAssets$116B2–0DGRO winsEnd-of-day Nov 18, 2026
Overlap: BIOY, JEPQ, VIGToday26.3%most shared, JEPQ and VIGBIOYJEPQVIGBIOY—[…][…]JEPQ[…]—26.3%VIG[…]26.3%—End-of-day Nov 18, 2026 · share held in common · outlined: the pair in versus
Income After Fees on $10,0001Y$2,308most kept, BIOYBIOY$3,806 − $1,498 = $2,308JEPQ$1,271 − $35 = $1,236VIG$149 − $4 = $145KeptFeeEnd-of-day Nov 18, 2026 · yield in dollars minus the fee